SLFN11 and small cell lung carcinoma: In contrast, we report robust SLFN11 expression in patient 29 (SCLC, H-score of 163), consistent with the findings that higher SLFN11 expression in SCLC is associated with improved prognosis, progression-free survival, and overall survival with DNA-damaging agents [43].